CompletedNot Applicable

Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis

Turkey (Türkiye)42 participantsStarted 2024-09-01

Plain-language summary

The aim of our study is to investigate the effects of pelvic floor muscle strengthening exercises with EMG-Biofeedback and pelvic floor muscle strengthening exercises with Rebound therapy on pelvic floor muscle strength, pain level, NGF level, perceived stress level, quality of life and sleep in women diagnosed with endometriosis.

Who can participate

Age range

20 Years – 50 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being between 20-50 years old, * Being diagnosed with endometriosis, * Completing the voluntary consent form, * Pain level being at least 4 on the Visual Analog Scale (VAS). Exclusion Criteria: Exclusion Criteria for the EMG-Biofeedback Group: * Being included in another study during the study period, * Being receiving medical treatment for endometriosis, * Presence of gynecological bleeding, * Presence of communication and cooperation problems, * Presence of tubo-ovarian abscess, * Active vaginal or urinary tract infection, * Pregnancy and giving birth within the last 12 months, * Presence of impaired somatosensory status, * Not attending 2 consecutive sessions. Exclusion Criteria for the Rebound Therapy Group: In addition to the exclusion criteria determined for the EMG-Biofeedback Group; * Presence of a neurological or orthopedic disease affecting the lower extremity, * History of spine and/or lower extremity orthopedic surgery, * Presence of severe arthritis affecting the spine and/or lower extremity, * Presence of uncontrolled hypertension and cardiovascular disease.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Pelvic floor muscle strength

Timeframe: 2 weeks

Pain Level

Timeframe: 2 weeks

Trial details

NCT IDNCT06517654

SponsorMedipol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-01

View on ClinicalTrials.gov More Endometriosis trials